Loading...

Purified Mouse IgG1, κ Isotype Ctrl Antibody Purified Mouse IgG1, κ Isotype Ctrl Antibody

Pricing & Availability
Clone
MG1-45 (See other available formats)
Regulatory Status
RUO
Isotype
Mouse (BALB/c) IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
  • MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
    Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
Cat # Size Price Quantity Check Availability Save
401401 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
401402 500 µg DKK767
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The isotype of MG1-45 immunoglobulin is mouse IgG1, κ. It was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.

Product Details
Technical Data Sheet (pdf)

Product Details

Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Trinitrophenol + KLH
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The immunoglobulin was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC, ICFC - Quality tested
ChIP - Verified
WB, IP, ICC, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control, and the purity is greater than 95% by SDS-PAGE. Use at concentrations comparable to those of the specific antibody of interest.

Application Notes

The MG1-45 immunoglobulin is useful as an isotype-matched control (for the relevant formats) for Western blotting, immunoprecipitation, immunohistochemistry, functional assay, immunofluorescence microscopy, immunocytochemistry and immunofluorescent staining (surface or intracellular) for flow cytometric analysis. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 401404) as negative control. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 401408) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Ozeki M, et al. 2008. J. Leukocyte Biol. 84:769. PubMed
  2. Kraetzel K, et al. 2008. Eur. Respair. J. 32:563. PubMed
  3. de Jong MA, et al. 2008. J Gen Virol. 89:2398. PubMed
  4. Romee R, et al. 2012 Blood. 120:4751. PubMed.
  5. Wong-Baeza I, et al. 2013. J. Immunol. 190:3216. PubMed.
Product Citations
  1. Frasca D, et al. 2020. Front Immunol. 11:392. PubMed
  2. Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed
  3. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  4. Staessens S, et al. 2022. J Thromb Haemost. 20:2058. PubMed
  5. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  6. El-Husseiny HM, et al. 2023. Int J Mol Sci. 24:. PubMed
  7. Wischnewski V, et al. 2023. Nat Cancer. . PubMed
  8. Gabaev I, et al. 2020. Cell Rep. 33:108249. PubMed
  9. Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed
  10. Melo-Gonzalez F, et al. 2018. J Biol Chem. 293:8543. PubMed
  11. Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed
  12. Sithole N, et al. 2020. Retrovirology. 17:6. PubMed
  13. Evesson F, et al. 2010. J Biol Chem. 285:28529. PubMed
  14. Wong-Baeza I, et al. 2013. J Immunol. 190:3216. PubMed
  15. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  16. Ai K, et al. 2022. PLoS Pathog. 18:e1010913. PubMed
  17. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  18. Adeniran BV, et al. 2021. Hum Reprod. 36:1871. PubMed
  19. Wahlig S, et al. 2020. Sci Rep. 1.584027778. PubMed
  20. Sun Z, et al. 2017. J Physiol. 595:1987. PubMed
  21. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  22. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  23. Subramaniyan B, et al. 2021. Viruses. 13:. PubMed
  24. Pir GJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  25. Wallis J, et al. 2020. Eur J Pharm Sci. 152:105456. PubMed
  26. Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed
  27. Seoane M, et al. 2019. Oncogene. 38:3616. PubMed
  28. Ji Y, et al. 2012. J Biol Chem. 287:24378. PubMed
  29. Hangiu O, et al. 2022. iScience. 25:104958. PubMed
  30. Wang F, et al. 2020. Int J Oncol. 57:707. PubMed
  31. Essig F, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Camilli G, et al. 2020. J Clin Invest. 130:4561. PubMed
  33. Huang CH, et al. 2019. ACS Nano. 13:11698. PubMed
  34. Matsuba S, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01538. PubMed
  35. Munoz O, et al. 2022. PLoS Pathog. 18:e1010673. PubMed
  36. Satchwell TJ, et al. 2019. Nat Commun. 10:3806. PubMed
  37. Vermi W, et al. 2018. Cancer Res. 78:3544. PubMed
  38. Fetz AE, et al. 2021. Acta Biomater. 130:281. PubMed
  39. Lavie L, et al. 2022. Front Neurol. 13:811916. PubMed
  40. Barzilai S, et al. 2016. J Leukoc Biol. 99: 1045 - 1055. PubMed
  41. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  42. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  43. Nasser H, et al. 2022. STAR Protoc. 3:101773. PubMed
  44. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  45. Jong M, et al. 2008. J Gen Virol. 89:2398. PubMed
  46. Suzuki R, et al. 2022. Nature. . PubMed
  47. Rolfes V, et al. 2020. Cell Reports. 31(6):107615. PubMed
  48. Staessens S, et al. 2019. Haematologica. 104(10). PubMed
  49. Hori Y, et al. 2022. Front Cardiovasc Med. 9:981088. PubMed
  50. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  51. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  52. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  53. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  54. Demetriou P, et al. 2020. Nat Immunol. 1232:21. PubMed
  55. Enomoto Y, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
  56. Camilli G, et al. 2018. Eur J Immunol. 48:757. PubMed
  57. Murayama M, et al. 2015. Nat Commun. 6: 8483. PubMed
  58. Kraetzel K, et al. 2008. Eur Respir J. 32:563. PubMed
  59. Shively M 2008. J Leukoc Biol. 84:769. PubMed
  60. Parashar D, et al. 2019. Cell Rep. 29:4389. PubMed
  61. Uttagomol J, et al. 2019. Int J Mol Sci. 5.153472222. PubMed
  62. Yakymiv Y, et al. 2021. Sci Rep. 11:21230. PubMed
  63. Huang Y, et al. 2021. Front Immunol. 12:649502. PubMed
  64. Romee R, et al. 2012. Blood. 120:4751. PubMed
  65. Wülfing C, et al. 2018. Immun Inflamm Dis. 0.495833333. PubMed
  66. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  67. Kauer J, et al. 2019. Sci Rep. 9:18337. PubMed
  68. Espinosa-Díez C, et al. 2018. Redox Biol. 14:88. PubMed
  69. Frasca D, et al. 2020. Front Immunol. 11:392. PubMed
  70. Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed
  71. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  72. Staessens S, et al. 2022. J Thromb Haemost. 20:2058. PubMed
  73. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  74. El-Husseiny HM, et al. 2023. Int J Mol Sci. 24:. PubMed
  75. Wischnewski V, et al. 2023. Nat Cancer. . PubMed
  76. Gabaev I, et al. 2020. Cell Rep. 33:108249. PubMed
  77. Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed
  78. Melo-Gonzalez F, et al. 2018. J Biol Chem. 293:8543. PubMed
  79. Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed
  80. Sithole N, et al. 2020. Retrovirology. 17:6. PubMed
  81. Evesson F, et al. 2010. J Biol Chem. 285:28529. PubMed
  82. Wong-Baeza I, et al. 2013. J Immunol. 190:3216. PubMed
  83. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  84. Ai K, et al. 2022. PLoS Pathog. 18:e1010913. PubMed
  85. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  86. Adeniran BV, et al. 2021. Hum Reprod. 36:1871. PubMed
  87. Wahlig S, et al. 2020. Sci Rep. 1.584027778. PubMed
  88. Sun Z, et al. 2017. J Physiol. 595:1987. PubMed
  89. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  90. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  91. Subramaniyan B, et al. 2021. Viruses. 13:. PubMed
  92. Pir GJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  93. Wallis J, et al. 2020. Eur J Pharm Sci. 152:105456. PubMed
  94. Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed
  95. Seoane M, et al. 2019. Oncogene. 38:3616. PubMed
  96. Ji Y, et al. 2012. J Biol Chem. 287:24378. PubMed
  97. Hangiu O, et al. 2022. iScience. 25:104958. PubMed
  98. Wang F, et al. 2020. Int J Oncol. 57:707. PubMed
  99. Essig F, et al. 2020. Int J Mol Sci. 21:00. PubMed
  100. Camilli G, et al. 2020. J Clin Invest. 130:4561. PubMed
  101. Huang CH, et al. 2019. ACS Nano. 13:11698. PubMed
  102. Matsuba S, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01538. PubMed
  103. Munoz O, et al. 2022. PLoS Pathog. 18:e1010673. PubMed
  104. Satchwell TJ, et al. 2019. Nat Commun. 10:3806. PubMed
  105. Vermi W, et al. 2018. Cancer Res. 78:3544. PubMed
  106. Fetz AE, et al. 2021. Acta Biomater. 130:281. PubMed
  107. Lavie L, et al. 2022. Front Neurol. 13:811916. PubMed
  108. Barzilai S, et al. 2016. J Leukoc Biol. 99: 1045 - 1055. PubMed
  109. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  110. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  111. Nasser H, et al. 2022. STAR Protoc. 3:101773. PubMed
  112. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  113. Jong M, et al. 2008. J Gen Virol. 89:2398. PubMed
  114. Suzuki R, et al. 2022. Nature. . PubMed
  115. Rolfes V, et al. 2020. Cell Reports. 31(6):107615. PubMed
  116. Staessens S, et al. 2019. Haematologica. 104(10). PubMed
  117. Hori Y, et al. 2022. Front Cardiovasc Med. 9:981088. PubMed
  118. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  119. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  120. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  121. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  122. Demetriou P, et al. 2020. Nat Immunol. 1232:21. PubMed
  123. Enomoto Y, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
  124. Camilli G, et al. 2018. Eur J Immunol. 48:757. PubMed
  125. Murayama M, et al. 2015. Nat Commun. 6: 8483. PubMed
  126. Kraetzel K, et al. 2008. Eur Respir J. 32:563. PubMed
  127. Shively M 2008. J Leukoc Biol. 84:769. PubMed
  128. Parashar D, et al. 2019. Cell Rep. 29:4389. PubMed
  129. Uttagomol J, et al. 2019. Int J Mol Sci. 5.153472222. PubMed
  130. Yakymiv Y, et al. 2021. Sci Rep. 11:21230. PubMed
  131. Huang Y, et al. 2021. Front Immunol. 12:649502. PubMed
  132. Romee R, et al. 2012. Blood. 120:4751. PubMed
  133. Wülfing C, et al. 2018. Immun Inflamm Dis. 0.495833333. PubMed
  134. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  135. Kauer J, et al. 2019. Sci Rep. 9:18337. PubMed
  136. Espinosa-Díez C, et al. 2018. Redox Biol. 14:88. PubMed
RRID
AB_2801452 (BioLegend Cat. No. 401401)
AB_2801451 (BioLegend Cat. No. 401402)

Antigen Details

Gene ID
NA

Related FAQs

There are no FAQs for this product.

Other Formats

View All Reagents
Description Clone Applications
Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,ICC,IHC,IP,WB,ChIP
Ultra-LEAF™ Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,WB,IP,ICC,IHC,FA
Go To Top Version: 3    Revision Date: 08/24/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
MG1-45 (See other available formats)
Regulatory Status
RUO
Isotype
Mouse (BALB/c) IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
  • MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
    Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
Cat # Size Price Quantity Check Availability Save
401401 50 µg DKK280
Check Availability


Need larger quantities of this item?
Request Bulk Quote
401402 500 µg DKK767
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The isotype of MG1-45 immunoglobulin is mouse IgG1, κ. It was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.

Product Details
Technical Data Sheet (pdf)

Product Details

Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Trinitrophenol + KLH
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The immunoglobulin was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC, ICFC - Quality tested
ChIP - Verified
WB, IP, ICC, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control, and the purity is greater than 95% by SDS-PAGE. Use at concentrations comparable to those of the specific antibody of interest.

Application Notes

The MG1-45 immunoglobulin is useful as an isotype-matched control (for the relevant formats) for Western blotting, immunoprecipitation, immunohistochemistry, functional assay, immunofluorescence microscopy, immunocytochemistry and immunofluorescent staining (surface or intracellular) for flow cytometric analysis. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 401404) as negative control. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 401408) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Ozeki M, et al. 2008. J. Leukocyte Biol. 84:769. PubMed
  2. Kraetzel K, et al. 2008. Eur. Respair. J. 32:563. PubMed
  3. de Jong MA, et al. 2008. J Gen Virol. 89:2398. PubMed
  4. Romee R, et al. 2012 Blood. 120:4751. PubMed.
  5. Wong-Baeza I, et al. 2013. J. Immunol. 190:3216. PubMed.
Product Citations
  1. Frasca D, et al. 2020. Front Immunol. 11:392. PubMed
  2. Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed
  3. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  4. Staessens S, et al. 2022. J Thromb Haemost. 20:2058. PubMed
  5. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  6. El-Husseiny HM, et al. 2023. Int J Mol Sci. 24:. PubMed
  7. Wischnewski V, et al. 2023. Nat Cancer. . PubMed
  8. Gabaev I, et al. 2020. Cell Rep. 33:108249. PubMed
  9. Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed
  10. Melo-Gonzalez F, et al. 2018. J Biol Chem. 293:8543. PubMed
  11. Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed
  12. Sithole N, et al. 2020. Retrovirology. 17:6. PubMed
  13. Evesson F, et al. 2010. J Biol Chem. 285:28529. PubMed
  14. Wong-Baeza I, et al. 2013. J Immunol. 190:3216. PubMed
  15. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  16. Ai K, et al. 2022. PLoS Pathog. 18:e1010913. PubMed
  17. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  18. Adeniran BV, et al. 2021. Hum Reprod. 36:1871. PubMed
  19. Wahlig S, et al. 2020. Sci Rep. 1.584027778. PubMed
  20. Sun Z, et al. 2017. J Physiol. 595:1987. PubMed
  21. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  22. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  23. Subramaniyan B, et al. 2021. Viruses. 13:. PubMed
  24. Pir GJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  25. Wallis J, et al. 2020. Eur J Pharm Sci. 152:105456. PubMed
  26. Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed
  27. Seoane M, et al. 2019. Oncogene. 38:3616. PubMed
  28. Ji Y, et al. 2012. J Biol Chem. 287:24378. PubMed
  29. Hangiu O, et al. 2022. iScience. 25:104958. PubMed
  30. Wang F, et al. 2020. Int J Oncol. 57:707. PubMed
  31. Essig F, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Camilli G, et al. 2020. J Clin Invest. 130:4561. PubMed
  33. Huang CH, et al. 2019. ACS Nano. 13:11698. PubMed
  34. Matsuba S, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01538. PubMed
  35. Munoz O, et al. 2022. PLoS Pathog. 18:e1010673. PubMed
  36. Satchwell TJ, et al. 2019. Nat Commun. 10:3806. PubMed
  37. Vermi W, et al. 2018. Cancer Res. 78:3544. PubMed
  38. Fetz AE, et al. 2021. Acta Biomater. 130:281. PubMed
  39. Lavie L, et al. 2022. Front Neurol. 13:811916. PubMed
  40. Barzilai S, et al. 2016. J Leukoc Biol. 99: 1045 - 1055. PubMed
  41. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  42. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  43. Nasser H, et al. 2022. STAR Protoc. 3:101773. PubMed
  44. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  45. Jong M, et al. 2008. J Gen Virol. 89:2398. PubMed
  46. Suzuki R, et al. 2022. Nature. . PubMed
  47. Rolfes V, et al. 2020. Cell Reports. 31(6):107615. PubMed
  48. Staessens S, et al. 2019. Haematologica. 104(10). PubMed
  49. Hori Y, et al. 2022. Front Cardiovasc Med. 9:981088. PubMed
  50. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  51. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  52. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  53. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  54. Demetriou P, et al. 2020. Nat Immunol. 1232:21. PubMed
  55. Enomoto Y, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
  56. Camilli G, et al. 2018. Eur J Immunol. 48:757. PubMed
  57. Murayama M, et al. 2015. Nat Commun. 6: 8483. PubMed
  58. Kraetzel K, et al. 2008. Eur Respir J. 32:563. PubMed
  59. Shively M 2008. J Leukoc Biol. 84:769. PubMed
  60. Parashar D, et al. 2019. Cell Rep. 29:4389. PubMed
  61. Uttagomol J, et al. 2019. Int J Mol Sci. 5.153472222. PubMed
  62. Yakymiv Y, et al. 2021. Sci Rep. 11:21230. PubMed
  63. Huang Y, et al. 2021. Front Immunol. 12:649502. PubMed
  64. Romee R, et al. 2012. Blood. 120:4751. PubMed
  65. Wülfing C, et al. 2018. Immun Inflamm Dis. 0.495833333. PubMed
  66. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  67. Kauer J, et al. 2019. Sci Rep. 9:18337. PubMed
  68. Espinosa-Díez C, et al. 2018. Redox Biol. 14:88. PubMed
  69. Frasca D, et al. 2020. Front Immunol. 11:392. PubMed
  70. Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed
  71. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  72. Staessens S, et al. 2022. J Thromb Haemost. 20:2058. PubMed
  73. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  74. El-Husseiny HM, et al. 2023. Int J Mol Sci. 24:. PubMed
  75. Wischnewski V, et al. 2023. Nat Cancer. . PubMed
  76. Gabaev I, et al. 2020. Cell Rep. 33:108249. PubMed
  77. Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed
  78. Melo-Gonzalez F, et al. 2018. J Biol Chem. 293:8543. PubMed
  79. Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed
  80. Sithole N, et al. 2020. Retrovirology. 17:6. PubMed
  81. Evesson F, et al. 2010. J Biol Chem. 285:28529. PubMed
  82. Wong-Baeza I, et al. 2013. J Immunol. 190:3216. PubMed
  83. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  84. Ai K, et al. 2022. PLoS Pathog. 18:e1010913. PubMed
  85. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  86. Adeniran BV, et al. 2021. Hum Reprod. 36:1871. PubMed
  87. Wahlig S, et al. 2020. Sci Rep. 1.584027778. PubMed
  88. Sun Z, et al. 2017. J Physiol. 595:1987. PubMed
  89. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  90. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  91. Subramaniyan B, et al. 2021. Viruses. 13:. PubMed
  92. Pir GJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  93. Wallis J, et al. 2020. Eur J Pharm Sci. 152:105456. PubMed
  94. Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed
  95. Seoane M, et al. 2019. Oncogene. 38:3616. PubMed
  96. Ji Y, et al. 2012. J Biol Chem. 287:24378. PubMed
  97. Hangiu O, et al. 2022. iScience. 25:104958. PubMed
  98. Wang F, et al. 2020. Int J Oncol. 57:707. PubMed
  99. Essig F, et al. 2020. Int J Mol Sci. 21:00. PubMed
  100. Camilli G, et al. 2020. J Clin Invest. 130:4561. PubMed
  101. Huang CH, et al. 2019. ACS Nano. 13:11698. PubMed
  102. Matsuba S, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01538. PubMed
  103. Munoz O, et al. 2022. PLoS Pathog. 18:e1010673. PubMed
  104. Satchwell TJ, et al. 2019. Nat Commun. 10:3806. PubMed
  105. Vermi W, et al. 2018. Cancer Res. 78:3544. PubMed
  106. Fetz AE, et al. 2021. Acta Biomater. 130:281. PubMed
  107. Lavie L, et al. 2022. Front Neurol. 13:811916. PubMed
  108. Barzilai S, et al. 2016. J Leukoc Biol. 99: 1045 - 1055. PubMed
  109. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  110. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  111. Nasser H, et al. 2022. STAR Protoc. 3:101773. PubMed
  112. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  113. Jong M, et al. 2008. J Gen Virol. 89:2398. PubMed
  114. Suzuki R, et al. 2022. Nature. . PubMed
  115. Rolfes V, et al. 2020. Cell Reports. 31(6):107615. PubMed
  116. Staessens S, et al. 2019. Haematologica. 104(10). PubMed
  117. Hori Y, et al. 2022. Front Cardiovasc Med. 9:981088. PubMed
  118. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  119. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  120. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  121. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  122. Demetriou P, et al. 2020. Nat Immunol. 1232:21. PubMed
  123. Enomoto Y, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
  124. Camilli G, et al. 2018. Eur J Immunol. 48:757. PubMed
  125. Murayama M, et al. 2015. Nat Commun. 6: 8483. PubMed
  126. Kraetzel K, et al. 2008. Eur Respir J. 32:563. PubMed
  127. Shively M 2008. J Leukoc Biol. 84:769. PubMed
  128. Parashar D, et al. 2019. Cell Rep. 29:4389. PubMed
  129. Uttagomol J, et al. 2019. Int J Mol Sci. 5.153472222. PubMed
  130. Yakymiv Y, et al. 2021. Sci Rep. 11:21230. PubMed
  131. Huang Y, et al. 2021. Front Immunol. 12:649502. PubMed
  132. Romee R, et al. 2012. Blood. 120:4751. PubMed
  133. Wülfing C, et al. 2018. Immun Inflamm Dis. 0.495833333. PubMed
  134. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  135. Kauer J, et al. 2019. Sci Rep. 9:18337. PubMed
  136. Espinosa-Díez C, et al. 2018. Redox Biol. 14:88. PubMed
RRID
AB_2801452 (BioLegend Cat. No. 401401)
AB_2801451 (BioLegend Cat. No. 401402)

Antigen Details

Gene ID
NA

Other Formats

View All Reagents
Description Clone Applications
Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,ICC,IHC,IP,WB,ChIP
Ultra-LEAF™ Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,WB,IP,ICC,IHC,FA
Go To Top Version: 3    Revision Date: 08/24/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account